The already sluggish development of Covid-19 vaccines and treatments in Korea has run into another obstacle – confusion resulting from the different positions of the Food and Drug Safety Ministry and drugmakers over emergency use approval.The drug makers have shown confidence in receiving emergency
Genexine said Thursday that it has signed a deal with Turret Capital of the United States to transfer the technology of its GX-P1, a PD-L1 (programmed death-ligand 1) immunosuppressive candidate.Under the agreement, Turret Capital, a global healthcare-focused investment and venture-building company,
MedPacto said Thursday that it would raise 100 billion won ($90 million) by issuing convertible preferred stocks and privately placed convertible bonds to conduct the clinical trials of Vactosertib that treats rare and intractable diseases.MedPacto, a biomarker-based new drug developer, explained th
Hanmi Pharmaceutical said that Spectrum, its U.S. partner, will apply for new drug approval (NDA) for poziotinib, a non-small cell lung cancer (NSCLC) treatment, in the U.S. next year."Spectrum said the U.S. Food and Drug Administration allowed Spectrum to submit an NDA request to a preliminary meet
The Ministry of Food and Drug Safety temporarily banned the manufacture, sales, and use of Medytox's botulinum toxin Innotox and began preparation to revoke its approval on Tuesday.The move comes after the ministry canceled the permission of the company's 50, 100, 150, and 200 units of Meditoxin and
Korean biotech firm ST Pharm is riding on the market’s attention on Moderna’s mRNA technology used to develop its Covid-19 vaccine.Earlier this month, the subsidiary of Dong-A Socio Holdings announced that it would enter a contract development and manufacturing organization (CDMO) business to manufa
Executives at ST Pharm have recently sold off their shares, drawing attention from investors in the pharmaceutical sector.In a public filing on Monday, the company said that three out of six executives sold stocks this month.The stock selling came at an unexpected timing because observers forecast t
Korean pharmaceutical companies have set about to develop treatments and vaccines that can respond to mutated coronavirus strain, including the variant that recently emerged in the United Kingdom.Daewoong Pharmaceutical said its Covid-19 therapy, candidate DWRX2003 (ingredient: niclosamide), now bei
Daewoong Pharmaceuticals said Tuesday it has confirmed the potency stability of its botulinum product, Nabota, under various temperatures.Potency stability refers to the product's efficacy and safety or maintaining potency in several conditions, including room temperature, refrigeration, and freezin
Domestic pharmaceutical companies are preparing to take legal action against the government's recent order to recollect insurance money paid for choline alfoscerate drugs if they fail to prove efficacy in re-evaluation.Local drugmakers had already filed a case over the government's previous decision
Pfizer has requested the Ministry of Food and Drug Safety for a preliminary assessment on non-clinical and clinical data of its investigational Covid-19 vaccine, BNT162b2, being jointly developed with BioNTech.On Friday, the MFDS said it received Pfizer’s application for the preliminary review, whic
Multinational pharmaceutical companies said they would offer paid holidays and gifts to employees who had to work as usual despite the Covid-19 pandemic this year.AstraZeneca Korea said its global headquarters gave all employees a special two-week holiday starting from Monday, with a letter from Ast
AbbVie recently released a comparison study saying its atopic dermatitis (AD) Rinvoq (ingredient: upadacitinib) was superior to Sanofi’s rival drug Dupixent (dupilumab).However, Sanofi refuted AbbVie’s claim, saying Dupixent was safer in long-term use.Dupixent is Sanofi’s latest AD treatment, which
Korean pharmaceutical companies are rushing to enter the cold chain business, forecasting that the supply need for Covid-19 vaccines will surge soon. A cold chain refers to a temperature-controlled supply system where refrigerated production, storage, and drug distribution are uninterrupted.Itek sai
The Korea Exchange (KRX) decided to delay deciding whether to delist Kolon TissueGene from the Kosdaq market for at least another year and did not allow a resumption of stock trading.The company must submit to the regulator a report that it had implemented its improvement plan and an expert’s verifi
Peptron said Friday it has applied for a patent on a week-lasting injection of Saxenda, a daily injection for obesity treatment manufactured by Novo Nordisk.Despite its hasty process of daily injections, Saxenda rapidly became popular because it was not a psychotropic drug and it showed excellent ef
A typhoid conjugate vaccine (TCV), jointly developed by the International Vaccine Institute and SK Bioscience, has met its primary endpoint in phase 3 clinical trials in Nepal, the IVI said on Thursday.The primary endpoint was to compare immune non-inferiority with Typbar-TCV, the current WHO-prequa
Huons Global said it would spin off its bio business and establish it as a separate subsidiary called Huons Biopharma by next April.Huons Biopharma will be capitalized at 2 billion won ($1.8 million), and the company will promote the group's bio business, such as botulinum toxin, and develop new dru
The U.S. International Trade Commission has upheld the preliminary decision that Daewoong Pharmaceutical copied Medytox's manufacturing process of its botulinum toxin product.ITC ordered a 21-month ban on the export of Daewoong Pharmaceutical's BTX products, Nabota, to the U.S.However, the final rul
“Vedolizumab showed a faster efficacy than conventional TNF-α blockers in the first-line biological treatment of ulcerative colitis (UC). The agent was particularly potent and safe in healing the intestinal mucosa, which is crucial for prognosis. Vedolizumab demonstrated the strongest effect in the